Literature DB >> 19528667

Association of chromosome 8q variants with prostate cancer risk in Caucasian and Hispanic men.

Joke Beuten1, Jonathan A L Gelfond, Margarita L Martinez-Fierro, Korri S Weldon, AnaLisa C Crandall, Augusto Rojas-Martinez, Ian M Thompson, Robin J Leach.   

Abstract

Genotyping of a 615 kb region within 8q24 with 49 haplotype-tagged single-nucleotide polymorphisms (SNPs) in 2109 samples (797 cases and 1312 controls) of two ethnic/racial groups found SNPs that are significantly associated with the risk for prostate cancer (PCa). The highest significance in Caucasian men was found for rs6983267; the AA genotype reduced the risk for PCa [odds ratio (OR) = 0.48, 95% confidence interval (CI) = 0.35-0.65, P = 2.74 x 10(-6)]. This SNP also had a significant independent effect from other SNPs in the region in this group. In Hispanic men, rs7837328 and rs921146 showed independent effects (OR = 2.55, 95% CI = 1.51-4.31, P = 4.33 x 10(-4), OR = 2.09, 95% CI = 1.40-3.12, P = 3.13 x 10(-4), respectively). Significant synergist effects for increasing numbers of high-risk alleles were found in both ethnicities. Haplotype analysis revealed major haplotypes, containing the non-risk alleles, conferred protection against PCa. We found high linkage disequilibrium between significant SNPs within the region and SNPs within the CUB and Sushi Multiple Domains 1 gene (CSMD1), on the short arm of chromosome 8 in both ethnicities. These data suggest that multiple interacting SNPs within 8q24, as well as different regions on chromosome 8 far beyond this 8q24 candidate region, may confer increased risk of PCa. This is the first report to investigate the involvement of 8q24 variants in the susceptibility for PCa in Hispanic men.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19528667      PMCID: PMC2718079          DOI: 10.1093/carcin/bgp148

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  43 in total

1.  Progenetix.net: an online repository for molecular cytogenetic aberration data.

Authors:  M Baudis; M L Cleary
Journal:  Bioinformatics       Date:  2001-12       Impact factor: 6.937

2.  Statistical significance for genomewide studies.

Authors:  John D Storey; Robert Tibshirani
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-25       Impact factor: 11.205

3.  Simple estimates of haplotype relative risks in case-control data.

Authors:  Benjamin French; Thomas Lumley; Stephanie A Monks; Kenneth M Rice; Lucia A Hindorff; Alexander P Reiner; Bruce M Psaty
Journal:  Genet Epidemiol       Date:  2006-09       Impact factor: 2.135

4.  FHX, a novel fork head factor with a dual DNA binding specificity.

Authors:  C Pérez-Sánchez; M A Gómez-Ferrería; C A de La Fuente; B Granadino; G Velasco; A Esteban-Gamboa; J Rey-Campos
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

5.  Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer.

Authors:  Paul J Adam; Robert Boyd; Kerry L Tyson; Graham C Fletcher; Alasdair Stamps; Lindsey Hudson; Helen R Poyser; Nick Redpath; Matthew Griffiths; Graham Steers; Adrian L Harris; Sonal Patel; Joanne Berry; Julie A Loader; R Reid Townsend; Laurent Daviet; Pierre Legrain; Raj Parekh; Jonathan A Terrett
Journal:  J Biol Chem       Date:  2002-12-10       Impact factor: 5.157

6.  Transcript map of the 8p23 putative tumor suppressor region.

Authors:  P C Sun; R Uppaluri; A P Schmidt; M E Pashia; E C Quant; J B Sunwoo; S M Gollin; S B Scholnick
Journal:  Genomics       Date:  2001-07       Impact factor: 5.736

7.  Oct4A is expressed by a subpopulation of prostate neuroendocrine cells.

Authors:  Paula Sotomayor; Alejandro Godoy; Gary J Smith; Wendy J Huss
Journal:  Prostate       Date:  2009-03-01       Impact factor: 4.104

8.  CSMD1 is a novel multiple domain complement-regulatory protein highly expressed in the central nervous system and epithelial tissues.

Authors:  Damian M Kraus; Gary S Elliott; Hilary Chute; Thomas Horan; Karl H Pfenninger; Staci D Sanford; Stephen Foster; Sheila Scully; Andrew A Welcher; V Michael Holers
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

9.  Cancer-specific loss of beta-defensin 1 in renal and prostatic carcinomas.

Authors:  Carlton D Donald; Carrie Q Sun; So Dug Lim; Jill Macoska; Cynthia Cohen; Mahul B Amin; Andrew N Young; Tomas A Ganz; Fray F Marshall; John A Petros
Journal:  Lab Invest       Date:  2003-04       Impact factor: 5.662

Review 10.  Chromosomal deletions and tumor suppressor genes in prostate cancer.

Authors:  J T Dong
Journal:  Cancer Metastasis Rev       Date:  2001       Impact factor: 9.264

View more
  22 in total

1.  Racial disparities in the association between variants on 8q24 and prostate cancer: a systematic review and meta-analysis.

Authors:  Sarah M Troutman; Tristan M Sissung; Cheryl D Cropp; David J Venzon; Shawn D Spencer; Bamidele A Adesunloye; Xuan Huang; Fatima H Karzai; Douglas K Price; William D Figg
Journal:  Oncologist       Date:  2012-03-01

2.  Genetic heterogeneity in Finnish hereditary prostate cancer using ordered subset analysis.

Authors:  Claire L Simpson; Cheryl D Cropp; Tiina Wahlfors; Asha George; Marypat S Jones; Ursula Harper; Damaris Ponciano-Jackson; Teuvo Tammela; Johanna Schleutker; Joan E Bailey-Wilson
Journal:  Eur J Hum Genet       Date:  2012-09-05       Impact factor: 4.246

3.  Common variants at 8q24 are associated with prostate cancer risk in Serbian population.

Authors:  Ana S Branković; Goran N Brajušković; Jovan D Mirčetić; Zorana Z Nikolić; Predrag B Kalaba; Vinka D Vukotić; Saša M Tomović; Snežana J Cerović; Zoran A Radojičić; Dušanka L J Savić-Pavićević; Stanka P Romac
Journal:  Pathol Oncol Res       Date:  2013-03-28       Impact factor: 3.201

4.  Correlation between Genomic Variants and Worldwide Epidemiology of Prostate Cancer.

Authors:  Giovana Miranda Vieira; Laura Patrícia Albarello Gellen; Diana Feio da Veiga Borges Leal; Lucas Favacho Pastana; Lui Wallacy Morikawa Souza Vinagre; Vitória Teixeira Aquino; Marianne Rodrigues Fernandes; Paulo Pimentel de Assumpção; Rommel Mario Rodríguez Burbano; Sidney Emanuel Batista Dos Santos; Ney Pereira Carneiro Dos Santos
Journal:  Genes (Basel)       Date:  2022-06-10       Impact factor: 4.141

5.  Application of a novel score test for genetic association incorporating gene-gene interaction suggests functionality for prostate cancer susceptibility regions.

Authors:  Julia Ciampa; Meredith Yeager; Kevin Jacobs; Michael J Thun; Susan Gapstur; Demetrius Albanes; Jarmo Virtamo; Stephanie J Weinstein; Edward Giovannucci; Walter C Willett; Geraldine Cancel-Tassin; Olivier Cussenot; Antoine Valeri; David Hunter; Robert Hoover; Gilles Thomas; Stephen Chanock; Chris Holmes; Nilanjan Chatterjee
Journal:  Hum Hered       Date:  2011-11-11       Impact factor: 0.444

6.  Validation of genome-wide prostate cancer associations in men of African descent.

Authors:  Bao-Li Chang; Elaine Spangler; Stephen Gallagher; Christopher A Haiman; Brian Henderson; William Isaacs; Marnita L Benford; LaCreis R Kidd; Kathleen Cooney; Sara Strom; Sue Ann Ingles; Mariana C Stern; Roman Corral; Amit D Joshi; Jianfeng Xu; Veda N Giri; Benjamin Rybicki; Christine Neslund-Dudas; Adam S Kibel; Ian M Thompson; Robin J Leach; Elaine A Ostrander; Janet L Stanford; John Witte; Graham Casey; Rosalind Eeles; Ann W Hsing; Stephen Chanock; Jennifer J Hu; Esther M John; Jong Park; Klara Stefflova; Charnita Zeigler-Johnson; Timothy R Rebbeck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-11-11       Impact factor: 4.254

7.  Evaluating genetic risk for prostate cancer among Japanese and Latinos.

Authors:  Iona Cheng; Gary K Chen; Hidewaki Nakagawa; Jing He; Peggy Wan; Cathy C Laurie; Jess Shen; Xin Sheng; Loreall C Pooler; Andrew T Crenshaw; Daniel B Mirel; Atsushi Takahashi; Michiaki Kubo; Yusuke Nakamura; Ali Amin Al Olama; Sara Benlloch; Jenny L Donovan; Michelle Guy; Freddie C Hamdy; Zsofia Kote-Jarai; David E Neal; Lynne R Wilkens; Kristine R Monroe; Daniel O Stram; Kenneth Muir; Rosalind A Eeles; Douglas F Easton; Laurence N Kolonel; Brian E Henderson; Loïc Le Marchand; Christopher A Haiman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-08-24       Impact factor: 4.254

8.  Somatic mutations, allele loss, and DNA methylation of the Cub and Sushi Multiple Domains 1 (CSMD1) gene reveals association with early age of diagnosis in colorectal cancer patients.

Authors:  Austin Y Shull; Megan L Clendenning; Sampa Ghoshal-Gupta; Christopher L Farrell; Hima V Vangapandu; Larry Dudas; Brent J Wilkerson; Phillip J Buckhaults
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

9.  Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent.

Authors:  Timothy R Rebbeck; Susan S Devesa; Bao-Li Chang; Clareann H Bunker; Iona Cheng; Kathleen Cooney; Rosalind Eeles; Pedro Fernandez; Veda N Giri; Serigne M Gueye; Christopher A Haiman; Brian E Henderson; Chris F Heyns; Jennifer J Hu; Sue Ann Ingles; William Isaacs; Mohamed Jalloh; Esther M John; Adam S Kibel; Lacreis R Kidd; Penelope Layne; Robin J Leach; Christine Neslund-Dudas; Michael N Okobia; Elaine A Ostrander; Jong Y Park; Alan L Patrick; Catherine M Phelan; Camille Ragin; Robin A Roberts; Benjamin A Rybicki; Janet L Stanford; Sara Strom; Ian M Thompson; John Witte; Jianfeng Xu; Edward Yeboah; Ann W Hsing; Charnita M Zeigler-Johnson
Journal:  Prostate Cancer       Date:  2013-02-13

10.  Assessment of behaviors modeling aspects of schizophrenia in Csmd1 mutant mice.

Authors:  Margaret G Distler; Mark D Opal; Stephanie C Dulawa; Abraham A Palmer
Journal:  PLoS One       Date:  2012-12-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.